182 related articles for article (PubMed ID: 15261226)
1. Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome.
Stylli SS; Howes M; MacGregor L; Rajendra P; Kaye AH
J Clin Neurosci; 2004 Aug; 11(6):584-96. PubMed ID: 15261226
[TBL] [Abstract][Full Text] [Related]
2. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
3. [Photodynamic therapy of malignant brain tumors].
Kostron H; Grunert V
Wien Klin Wochenschr; 1987 May; 99(11):389-92. PubMed ID: 2956770
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of high grade glioma - long term survival.
Stylli SS; Kaye AH; MacGregor L; Howes M; Rajendra P
J Clin Neurosci; 2005 May; 12(4):389-98. PubMed ID: 15925768
[TBL] [Abstract][Full Text] [Related]
5. Selective uptake of hematoporphyrin derivative into human cerebral glioma.
Hill JS; Kaye AH; Sawyer WH; Morstyn G; Megison PD; Stylli SS
Neurosurgery; 1990 Feb; 26(2):248-54. PubMed ID: 2137904
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma.
Arvind S; Arivazhagan A; Santosh V; Chandramouli BA
Br J Neurosurg; 2012 Feb; 26(1):16-20. PubMed ID: 21707241
[TBL] [Abstract][Full Text] [Related]
7. [Hematoporphyrin derivative-mediated photodynamic therapy for human nasopharyngeal carcinoma: a comparative study with CNE2 and C666-1 cell lines in vitro].
Yang XM; Luo RC; Ma HJ; Li LB; Ding XM; Yan X; Lü CW; Zhou XP
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):165-7. PubMed ID: 17355926
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration.
Yoshida T; Tokashiki R; Ito H; Shimizu A; Nakamura K; Hiramatsu H; Tsukahara K; Shimizu S; Takata D; Okamoto I; Suzuki M
Auris Nasus Larynx; 2008 Dec; 35(4):545-51. PubMed ID: 18242905
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic diagnosis and therapy and the brain.
Kostron H
Methods Mol Biol; 2010; 635():261-80. PubMed ID: 20552352
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of brain tumours.
Kaye AH; Hill JS
Ann Acad Med Singap; 1993 May; 22(3 Suppl):470-81. PubMed ID: 8215203
[TBL] [Abstract][Full Text] [Related]
11. Time-resolved fluorescence spectroscopy of a hematoporphyrin derivative used for photodynamic therapy of cancer.
Gottschlich S; Lippert BM; Schade W; Werner JA
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):237-40. PubMed ID: 9467832
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
14. Influence of epidermal growth factor on photodynamic therapy of glioblastoma cells in vitro.
Fanuel-Barret D; Patrice T; Foultier MT; Vonarx-Coinsmann V; Robillard N; Lajat Y
Res Exp Med (Berl); 1997; 197(4):219-33. PubMed ID: 9440140
[TBL] [Abstract][Full Text] [Related]
15. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
16. Research progress of Hemoporfin--part one: preclinical study.
Pu Y; Chen W; Yu Z
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):180-5. PubMed ID: 22594989
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
El-Far M; Pimstone N
Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
19. Phototoxicity of brain tissue in hematoporphyrin derivative treated mice.
Rounds DE; Doiron DR; Jacques DB; Shelden CH; Olson RS
Prog Clin Biol Res; 1984; 170():613-28. PubMed ID: 6241701
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
Wang LF; Fokas E; Bieker M; Rose F; Rexin P; Zhu Y; Pagenstecher A; Engenhart-Cabillic R; An HX
Oncol Rep; 2008 Jan; 19(1):151-6. PubMed ID: 18097589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
